Peer Review History
| Original SubmissionAugust 28, 2025 |
|---|
|
Dear Dr. Kinyi, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Nov 08 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Rami Salim Najjar, Ph.D. Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1.Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. We note that your Data Availability Statement is currently as follows: All relevant data are within the manuscript and in Supporting Information files. Please confirm at this time whether or not your submission contains all raw data required to replicate the results of your study. Authors must share the “minimal data set” for their submission. PLOS defines the minimal data set to consist of the data required to replicate all study findings reported in the article, as well as related metadata and methods (https://journals.plos.org/plosone/s/data-availability#loc-minimal-data-set-definition). For example, authors should submit the following data: - The values behind the means, standard deviations and other measures reported; - The values used to build graphs; - The points extracted from images for analysis. Authors do not need to submit their entire data set if only a portion of the data was used in the reported study. If your submission does not contain these data, please either upload them as Supporting Information files or deposit them to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. For a list of recommended repositories, please see https://journals.plos.org/plosone/s/recommended-repositories. If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially sensitive information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent. If data are owned by a third party, please indicate how others may request data access. 3. Please ensure that you refer to Figure 4 in your text as, if accepted, production will need this reference to link the reader to the figure. 4. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information. 5. If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? Reviewer #1: Partly Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: Yes Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes Reviewer #2: Yes ********** Reviewer #1: Title: High-protein diets reduce plasma pro-inflammatory cytokines following lipopolysaccharide challenge in Swiss Albino mice Overall, the authors present a well-written manuscript addressing the need to elucidate the impact of macronutrient composition on the innate immune response. This reviewer has a few comments and questions: • The authors discuss the small sample size (n=3 per sex) in their limitations; however, in 2.2.2 and in Figure 1, the sample size is noted to be six male and six female. Furthermore, the sample size is not indicated in the captions of the results figures. Was there a loss in the samples? • A high-carbohydrate diet for 15 weeks can induce diabetes in mice such as C57s, was blood glucose measured in these animals? Did any animals exhibit signs of diabetes? • Can the authors provide rationale for not including a control group in which the macronutrient composition follows the standard recommendations? Or add it to the limitations? • Did the authors measure food intake? If so, it should be included alongside the changes in weight results. • Can the authors discuss any statistics on human consumption patterns that may align with the macronutrient compositions discussed here? For example, HLLC closely resembles a more extreme ketogenic diet. • Other comments: o On line 254: Authors may be referring to Figure 2, not Figure 1. o Lines 393 and 409: Please consider following the same phrasing for both or combining them into one section. o Periods are often missing throughout the manuscript after citations. Reviewer #2: The manuscript of Kinyi et al assessed macronutrient induced differences in cytokine induction following a challenge with LPS. This is a highly interesting and important topic of research as food plays a tremendous role in the regulation of health, including the immune system. The manuscript and methods are well described and results technically sound. My prime concern however, is about the interpretation of research findings. In particular, whether the rapid activation of four cytokines can be considered as a good or a bad sign. First, the authors describe subtle but significant alterations of plasma cytokine levels in unchallenged mice fed various well-balanced diets. As all animals are still of a very young age, it would be important to indicate which concentrations can still be considered within the normal range and which indeed exceed a certain threshold and can truly be considered elevated e.g., by measuring cytokine levels of control mice on the standard AIN93M-food or using reference values from literature. Second, they expose animals on diverse isocaloric diets to LPS and monitor the subsequent activation of cytokines 3 hours later. Here, I would rather suggest these increased levels to be an indication of how well the different animals can still cope with and respond to stress. This should be illustrated as additional figure according to as described by the authors in their methods section line 240-241: “Change in serum cytokine levels (� cytokine = Post LPS challenge level – Pro LPS challenge level) was calculated for each mouse.” Third, both high protein diets show less of an increase compared to the other diets, suggesting a reduced responsiveness. This scenario, in contrast to what is currently indicated in the discussion, would be fully in line with adverse health conditions driven by high protein diets and improved health by low protein diets (for example see Solon-Biet SM et al 2015 Proc Natl Acad Sci U S A DOI: 10.1073/pnas.1422041112, Kitada M et al 2019 EBioMedicine DOI: 10.1016/j.ebiom.2019.04.005, and van Galen I et al 2025 NPJ Metab Health Dis DOI: 10.1038/s44324-025-00064-3) and elaboration thereof within the discussion in light of the present cytokine date would further strengthen this manuscript. Fourth, the authors might want to reconsider changing the overall conclusions such as on line 37 “high dietary protein intake reduced pro-inflammatory responses” more into high dietary restriction dampened the responsiveness towards lipopolysaccharide challenge, as indicated by less increased pro-inflammatory cytokine levels. Also overstatements such as on line 357-358 “control mice fed on high-protein diets exhibited lower cytokine levels” should be avoided as this was not significantly lower and likely within the normal range. Fifth, many cytokines are under the control of circadian rhythm such as TNFa, IL6 and IL18. Was there any difference or correlation of cytokine levels with collection time or deviations between groups? Additional minor concerns are: - The authors should systematically correct textual and grammar issues e.g., dots are missing at the end of some sentences, a mixture of US and UK Engligh is used, reference to figures is frequently wrong and the reference list shows many inconsistencies. - In Table 1 also the basal CHO, Protein and Lipid levels of AIN93M food should be indicated along with indications on how much these levels are changed in the various diets. Also, I assume the percentage composition equals a macronutrient ratio as % Kcal. - Line 133-134 indicates that only animals that fulfilled the inclusion criteria were randomized across groups. Which inclusion criteria were used? - Line 252-254 reports on inconsistent highest and lowest diet groups compared to the data in Figure 2. - As male and female mice can have large differences in body weight and show some metabolic differences, the question arises if the diet induced changes in body weight gain over 15 weeks are consistent in both sexes. Showing this as e.g. supplemental separate graph for males and females would be of support. - All graphs show error bars without indication of what type of error was used. Is this SD, SEM, or 95% CI? - The manuscript would overall gain from some further mechanistic analysis by characterization of molecular changes of the pathways indicated following LPS challenge on the various diets. - Lastly, the authors should add any conflict of interest statement and indicate if and how AI was used. ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: No Reviewer #2: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
High-protein diets reduce plasma pro-inflammatory cytokines following lipopolysaccharide challenge in Swiss Albino mice PONE-D-25-44328R1 Dear Dr. Kinyi, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support . If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Rami Salim Najjar, Ph.D. Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author Reviewer #1: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions??> Reviewer #1: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes ********** Reviewer #1: Thank you to the authors for thoroughly addressing my previous comments and for the thoughtful revisions to their manuscript. ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: No ********** |
| Formally Accepted |
|
PONE-D-25-44328R1 PLOS One Dear Dr. Kinyi, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS One. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Rami Salim Najjar Academic Editor PLOS One |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .